Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration

Human Molecular Genetics

Volumn 14, Issue 11, 2005, Pages 1449-1455

  Zareparsi, Sepideh ^a   Buraczynska, Monika ^a   Branham, Kari E H ^a   Shah, Sapna ^a   Eng, Donna ^a   Li, Mingyao ^b   Pawar, Hemant ^a   Yashar, Beverly M ^a   Moroi, Sayoko E ^a   Lichter, Paul R ^a   Petty, Howard R ^a   Richards, Julia E ^a,b   Abecasis, Gonçalo R ^b   Elner, Victor M ^a   Swaroop, Anand ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; TOLL LIKE RECEPTOR 4;

ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CHOLESTEROL TRANSPORT; CHROMOSOME 9Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE PREDISPOSITION; GENE LOCATION; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN VARIANT; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK REDUCTION; SIGNAL TRANSDUCTION;

AGED; AGING; BASE SEQUENCE; COHORT STUDIES; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; VARIATION (GENETICS);

EID: 20544433415     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi154     Document Type: Article

References (66)

1. Klein, R., Klein, B.E. and Linton, K.L. (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 99, 933-943.
2. Vingerling, J.R., Dielemans, I., Hofman, A., Grobbee, D.E., Hijmering, M., Kramer, C.F. and de Jong, P.T. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology, 102, 205-210.
3. Friedman, D.S., O'Colmain, B.J., Munoz, B., Tomany, S.C., McCarty, C., de Jong, P.T., Nemesure, B., Mitchell, P. and Kempen, J. (2004) Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol., 122, 564-572.
4. Bok, D. (2002) New insights and new approaches toward the study of age-related macular degeneration. Proc. Natl Acad. Sci. USA, 99, 14619-14621.
5. Johnson, L.V., Leitner, W.P., Rivest, A.J., Staples, M.K., Radeke, M.J. and Anderson, D.H. (2002) The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration Proc. Natl Acad. Sci. USA, 99, 11830-11835.
6. Bird, A.C., Bressler, N.M., Bressler, S.B., Chisholm, I.H., Coscas, G., Davis, M.D., de Jong, P.T., Klaver, C.C., Klein, B.E., Klein, R. et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol., 39, 367-374.
7. Ambati, J., Ambati, B.K., Yoo, S.H., Ianchulev, S. and Adamis, A.P. (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol., 48, 257-293.
8. Gorin, M.B., Breitner, J.C., de Jong, P.T., Hageman, G.S., Klaver, C.C., Kuehn, M.H. and Seddon, J.M. (1999) The genetics of age-related macular degeneration. Mol. Vis., 5, 29.
9. Evans, J.R. (2001) Risk factors for age-related macular degeneration. Prog. Retin. Eye Res., 20, 227-253.
10. Klein,R., Peto, T., Bird, A. and Vannewkirk, M.R. (2004) The epidemiology of age-related macular degeneration. Am. J. Ophthalmol., 137, 486-495.
11. Klaver, C.C., Kliffen, M., van Duijn, C.M., Hoftnan, A., Cruts, M., Grobbee, D.E., van Broeckhoven, C. and de Jong, P.T. (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet., 63, 200-206.
12. Schmidt, S., Klaver, C., Saunders, A., Postel, E., de La Paz, M., Agarwal, A., Small, K., Udar, N., Ong, J., Chalukya, M. et al. (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet., 23, 209-223.
13. Zareparsi, S., Reddick, A.C., Branham, K.E., Moore, K.B., Jessup, L., Thoms, S., Smith-Wheelock, M., Yashar, B.M. and Swaroop, A. (2004) Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest. Ophthalmol. Vis. Sci., 45], 1306-1310.
14. Baird, P.N., Guida, E., Chu, D.T., Vu, H.T. and Guymer, R.H. (2004) The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 45, 1311-1315.
15. Edwards, A.O., Ritter Iii, R., Abel, K.J., Manning, A., Panhuysen, C. and Farrer, L.A. (2005) Complement factor H polymorphism and age-related macular degeneration. Science (10.1126/science.1110189).
16. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science (10.1126/science.1110359).
17. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., Sangiovanni, J.P., Mane, S.M., Mayne, S.T. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science (10.1126/science.1109557).
18. Rodriguez de Cordoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., Lopez-Trascasa, M. and Sanchez-Corral, P. (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol., 41, 355-367.
19. Weeks, D.E., Conley, Y.P., Mah, T.S., Paul, T.O., Morse, L., Ngo-Chang, J., Dailey, J.P., Ferrell, R.E. and Gorin, M.B. (2000) A full genome scan for age-related maculopathy. Hum. Mol. Genet., 9, 1329-1349.
20. Majewski, J., Schultz, D.W., Weleber, R.G., Schain, M.B., Edwards, A.O., Matise, T.C., Acott, T.S., Ott, J. and Klein, M.L. (2003) Age-related macular degeneration - a genome scan in extended families. Am. J. Hum. Genet., 73, 540-550.
21. Seddon, J.M., Santangelo, S.L., Book, K., Chong, S. and Cote, J. (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am. J. Hum. Genet., 73, 780-790.
22. Abecasis, G.R., Yashar, B.M., Zhao, Y., Ghiasvand, N.M., Zareparsi, S., Branham, K.E., Reddick, A.C., Trager, E.H., Yoshida, S., Bahling, J. et al. (2004) Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am. J. Hum. Genet., 74, 482-494.
23. Iyengar, S.K., Song, D., Klein, B.E., Klein, R., Schick, J.H., Humphrey, J., Millard, C., Liptak, R., Russo, K., Jun, G. et al. (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am. J. Hum. Genet., 74, 20-39.
24. Schmidt, S., Scott, W.K., Postel, E.A., Agarwal, A., Hauser, E.R., de La Paz, M.A., Gilbert, J.R., Weeks, D.E., Gorin, M.B., Haines, J.L. et al. (2004) Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16pl2. BMC Genet., 5, 18.
25. Weeks, D.E., Conley, Y.P., Tsai, H.J., Mah, T.S., Schmidt, S., Postel, E.A., Agarwal, A., Haines, J.L., Pericak-Vance, M.A., Rosenfeld, P.J. et al. (2004) Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am. J. Hum. Genet., 75, 174-189.
26. Klein, M.L., Schultz, D.W., Edwards, A., Matise, T.C., Rust, K., Berselli, C.B., Trzupek, K., Weleber, R.G., Ott, J., Wirtz, M.K. et al. (1998) Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch. Ophthalmol., 116, 1082-1088.
27. Schultz, D.W., Klein, M.L., Humpert, A.J., Luzier, C.W., Persun, V., Schain, M., Mahan, A., Runckel, C., Cassera, M., Vittal, V. et al. (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum. Mol. Genet., 12, 3315-3323.
28. Hayashi, M., Merriam, J.E., Klaver, C.C., Zernant, J., Bergen, A.A., Smith, R.T., Chang, S., Merriam, J.C. and Allikmets, R. (2004) Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet., 25, 111-119.
29. Allikmets, R., Shroyer, N.F., Singh, N., Seddon, J.M., Lewis, R.A., Bernstein, P.S., Peiffer, A., Zabriskie, N.A., Li, Y., Hutchinson, A. et al. (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science, 277, 1805-1807.
30. Stone, E.M., Webster, A.R., Vandenburgh, K., Streb, L.M., Hockey, R.R., Lotery, A.J. and Sheffield, V.C. (1998) Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat. Genet., 20, 328-329.
31. Stone, E.M., Sheffield, V.C. and Hageman, G.S. (2001) Molecular genetics of age-related macular degeneration. Hum. Mol. Genet., 10, 2285-2292.
32. Stone, E.M., Lotery, A.J., Munier, F.L., Heon, E., Piguet, B., Guymer, R.H., Vandenburgh, K., Cousin, P., Nishimura, D., Swiderski, R.E. et al. (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat. Genet., 22, 199-202.
33. Marmorstein, L.Y., Munier, F.L., Arsenijevic, Y., Schorderet, D.F., McLaughlin, P.J., Chung, D., Traboulsi, E. and Marmorstein, A.D. (2002) Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad. Sci USA, 99, 13067-13072.
34. Stone, E.M., Braun, T.A., Russell, S.R., Kuehn, M.H., Lotery, A.J., Moore, P.A., Eastman, C.G., Casavant, T.L. and Sheffield, V.C. (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N. Engl. J. Med., 351, 346-353.
35. Friedman, E. (2000) The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am. J. Ophthalmol., 130, 658-663.
36. Curcio, C.A., Millican, C.L., Bailey, T. and Kruth, H.S. (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci., 42, 265-274.
37. Humphries, S.E. and Morgan, L. (2004) Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol., 3, 227-235.
38. Anderson, D.H., Ozaki, S., Nealon, M., Neitz, J., Mullins, R.F., Hageman, G.S. and Johnson, L.V. (2001) Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol., 131, 767-781.
39. Hageman, G.S., Luthert, P.J., Victor Chong, N.H., Johnson, L.V., Anderson, D.H. and Mullins, R.F. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res., 20, 705-732.
40. Zarbin, M.A. (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol., 122, 598-614.
41. Libby, P. and Ridker, P.M. (2004) Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med., 116(Suppl. 6A), 9S-16S.
42. Seddon, J.M., Gensler, G., Milton, R.C., Klein, M.L. and Rifai, N. (2004) Association between C-reactive protein and age-related macular degeneration. JAMA, 291, 704-710.
43. Wilson, P.W., Schaefer, E.J., Larson, M.G. and Ordovas, J.M. (1996) Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler. Thromb. Vasc. Biol., 16, 1250-1255.
44. Armant, M.A. and Fenton, M.J. (2002) Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol., 3 (REVIEWS3011).
45. Cook, D.N., Pisetsky, D.S. and Schwartz, D.A. (2004) Toll-like receptors in the pathogenesis of human disease. Nat. Immunol., 5, 975-979.
46. Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C.J., Oberhollenzer, F., Bonora, E., Willeit, J. and Schwartz, D.A. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med., 347, 185-192.
47. Boekholdt, S.M., Agema, W.R., Peters, R.J., Zwinderman, A.H., van der Wall, E.E., Reitsma, P.H., Kastelein, J.J. and Jukema, J.W. (2003) Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation, 107, 2416-2421.
48. Castrillo, A., Joseph, S.B., Vaidya, S.A., Haberland, M., Fogelman, A.M., Cheng, G. and Tontonoz, P. (2003) Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell, 12, 805-816.
49. Gordon, S. (2003) Do macrophage innate immune receptors enhance atherogenesis? Dev. Cell, 5, 666-668.
50. Blander, J.M. and Medzhitov, R. (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science, 304, 1014-1018.
51. Kindzelskii, A.L., Elner, V.M., Elner, S.G., Yang, D., Hughes, B.A. and Petty, H.R. (2004) Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. J. Gen. Physiol., 124, 139-149.
52. Michel, O., LeVan, T.D., Stern, D., Dentener, M., Thorn, J., Gnat, D., Beijer, M.L., Cochaux, P., Holt, P.G., Martinez, F.D. et al. (2003) Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J. Allergy. Clin. Immunol., 112, 923-929.
53. Clee, S.M., Zwinderman, A.H., Engert, J.C., Zwarts, K.Y., Molhuizen, H.O., Roomp, K., Jukema, J.W., van Wijland, M., van Dam, M., Hudson, T.J. et al. (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation, 103, 1198-1205.
54. Crabb, J.W., Miyagi, M., Gu, X., Shadrach, K., West, K.A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M.E. et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA, 99, 14682-14687.
55. Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B.C., Kuziel, W.A., Rollins, B.J. and Ambati, B.K. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med., 9, 1390-1397.
56. Arbour, N.C., Lorenz, E., Schutte, B.C., Zabner, J., Kline, J.N., Jones, M., Frees, K., Watt, J.L. and Schwartz, D.A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet., 25, 187-191.
57. Janeway, C., Jr. and Medzhitov, R. (2000) Viral interference with IL-1 and toll signaling. Proc. Natl Acad. Sci. USA, 97, 10682-10683.
58. Joseph, S.B. and Tontonoz, P. (2003) LXRs: new therapeutic targets in atherosclerosis? Curr. Opin. Pharmacol., 3, 192-197.
59. Michelsen, K.S., Wong, M.H., Shah, P.K., Zhang, W., Yano, J., Doherty, TM, Akira, S, Rajavashisth, TB and Arditi, M (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl Acad. Sci. USA, 101, 10679-10684.
60. Walczak, R., Joseph, S.B., Laffitte, B.A., Castrillo, A., Pei, L. and Tontonoz, P. (2004) Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J. Biol. Chem., 279, 9905-9911.
61. Hoh, J. and Ott, J. (2004) Genetic dissection of diseases: design and methods. Curr. Opin. Genet. Dev., 14, 229-232.
62. Lorenz, E., Frees, K.L. and Schwartz, D.A. (2001) Determination of the TLR4 genotype using allele-specific PCR. Biotechniques, 31, 22-24.
63. Raby, B.A., Klimecki, W.T., Laprise, C., Renaud, Y., Faith, J., Lemire, M., Greenwood, C., Weiland, K.M., Lange, C., Palmer, L.J. et al. (2002) Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am. J. Respir. Crit. Care Med., 166, 1449-1456.
64. Hixson, J.E. and Vernier, D.T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res., 31, 545-548.
65. Wigginton, J.E., Cutler, D.J. and Abecasis, G.R. (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet., 76.
66. Searle, S.R. (1987) Linear models for unbalanced data. John Wiley, New York, pp. 887-893.